Mr Khan said:
The solution then would just be to de-regulate the distribution of all drugs, but big pharma would *hate* it. Actually something i could get behind, namely that you can't patent a distinct chemical compound. |
Clinical trials need to stay in some form. If the US had public healthcare it would be cost effective to entirely self-fund trials. Perhaps in conjunction with some EU systems.